Ramipril and Laryngeal nerve damage - a phase IV clinical study of FDA data

Summary:

Laryngeal nerve damage is reported as a side effect among people who take Ramipril (ramipril), especially for people who are male, 50-59 old, also take Xarelto, and have Joint pain.

The phase IV clinical study analyzes which people have Laryngeal nerve damage when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Laryngeal nerve damage?

Laryngeal nerve damage is found to be associated with 346 drugs and 611 conditions by eHealthMe. Check the latest studies of Laryngeal nerve damage.

On Jul, 15, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 21 people (0.01%) have Laryngeal nerve damage.

Could Ramipril cause Laryngeal nerve damage?

Among these 21 people:

What is the gender of people who have Laryngeal nerve damage when taking Ramipril? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Laryngeal nerve damage when taking Ramipril? *

What are other drugs people take besides Ramipril? *

Xarelto: 10 people, 47.62%
Pantoprazole: 9 people, 42.86%
Morphine: 7 people, 33.33%
Levothyroxine Sodium: 3 people, 14.29%
Metoclopramide Hydrochloride: 3 people, 14.29%
Oxaliplatin: 3 people, 14.29%
Zopiclone: 2 people, 9.52%
Atorvastatin Calcium: 2 people, 9.52%
Colecalciferol: 2 people, 9.52%
Isoptin: 2 people, 9.52%

What are other side effects people have besides Laryngeal nerve damage? *

Weight Decreased: 11 people, 52.38%
Cough: 10 people, 47.62%
Vocal Cord Inflammation: 9 people, 42.86%
Retching (strong involuntary effort to vomit): 9 people, 42.86%
Nausea And Vomiting: 9 people, 42.86%
Oropharyngeal Pain: 5 people, 23.81%
Dyspnea (difficult or laboured breathing): 4 people, 19.05%
Swallowing Difficulty: 3 people, 14.29%
Fatigue (feeling of tiredness): 3 people, 14.29%
Hypogeusia (reduced ability to taste things (to taste sweet, sour, bitter, or salty substances)): 2 people, 9.52%

What are the existing conditions these people have? *

Joint Pain: 7 people, 33.33%
High Blood Cholesterol: 3 people, 14.29%
Diabetes: 2 people, 9.52%
Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 9.52%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 2 people, 9.52%
Back Pain: 2 people, 9.52%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 9.52%
Lower Urinary Tract Symptoms: 2 people, 9.52%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 9.52%
Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Laryngeal nerve damage?

- Check whether Laryngeal nerve damage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,397 reports)

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Laryngeal nerve damage:

Laryngeal nerve damage (346 drugs)

Browse all the conditions that are associated with Laryngeal nerve damage:

Laryngeal nerve damage (611 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.